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Results: BAP level was higher in OA synovial ﬂuid than in simple
synovitis, and d-ROM level was slightness lower in OA than control
synovitis, but this differences were not signiﬁcant. BAP and d-ROM levels
were not related with OA grade.
After intra-articular injection of HA, BAP level was signiﬁcantly increased
and d-ROM level was reduced. On the other hand, BAP and d-ROM level
were signiﬁcantly decreased after injection of corticosteroid.
Conclusions: Oxidative stress and anti-oxidative potential in synovial
ﬂuid were not signiﬁcant difference between OA and simple synovitis.
Our results showed that hyaluronan increase the anti-oxidant potential
and decreased oxidative stress, but corticosteroid decreased both
oxidative stress and the anti-oxidative stress potential.
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Purpose: The pro-inﬂammatory lipid mediator prostaglandin E2 (PGE2)
is present in the osteoarthritic joint and is know to play a role
in osteoarthritis (OA). Both stimulated chondrocytes and synovial
ﬁbroblasts are capable of producing PGE2, however, to which extent
osteoarthritic joint tissue is involved in its production and if the PGE2
produced has an effect on cartilage degeneration and regeneration is not
entirely clear. Recently, we set up a coculture model with OA cartilage and
OA synovial tissue that demonstrated to be more representative for OA
than cartilage explant monocultures. To further clarify the role of PGE2
in osteoarthritis, the effect of blocking COX-2 and hence production of
PGE2, on cartilage degeneration and cartilage regeneration was studied
in the coculture model and in a chondrocyte 3D regeneration model,
respectively.
Methods: OA cartilage and OA synovial tissue were cultured alone or in
coculture for 21 days with the addition of celecoxib at 0.1, 1 and 10mM.
Cartilage regeneration in the presence of absence of 1mM celecoxib, was
studied by seeding healthy or osteoarthritic chondrocytes (P2) at high
density on collagen-coated ﬁlters and cultured for 28 days. As outcome
parameters, glycosaminoglycan (GAG) release and content, safranin-O
staining and PGE2 production were determined.
For statistical analysis, univariate analysis of variance was performed. To
correct for inter-donor variability a randomized block design was used.
P values <0.05 were considered signiﬁcant.
Results: Both osteoarthritic cartilage and synovial tissue produced PGE2,
albeit at much higher amounts by synovial tissue. Celecoxib inhibited
PGE2 production (Fig. 1) and at 10mM decreased glycosaminoglycan
(GAG) release in coculture (Fig. 1), however, had no effect on GAG content
in either cartilage monoculture or coculture with OA synovial tissue
(Fig. 1).
During regeneration, OA chondrocytes produced low amounts of PGE2,
which also could be inhibited by celecoxib (Fig 2; P< 0.05). However,
celecoxib had no effect on cartilage regeneration in either the healthy
and osteoarthritic chondrocytes (Fig. 2).
Conclusions: Osteoarthritic cartilage explants, OA chondrocytes and in
particular OA synovial tissue produced PGE2, which could be inhibited
by celecoxib, suggesting COX-2 was the main COX active in the tissue. In
coculture, celecoxib inhibited both PGE2 production and GAG release,
although no effect on GAG content was observed. During cartilage
regeneration, the decrease of the PGE2 production was not accompanied
by an effect on chondrocyte metabolism. This study shows that celecoxib
inhibits PGE2 production in both explant and regeneration culture,
however, its effect on cartilage metabolism is limited.
Fig. 1. PGE2 production, GAG release and GAG content in a coculture
model with OA cartilage and synovial tissue.
Fig. 2. Celecoxib decreases PGE2 production in OA chondrocytes
(*P < 0.05), however without effect on GAG content.
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MILD ELECTRICAL STIMULATION WITH HEAT SHOCK INCREASES
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Sch. of Med. Sci., Kyoto Prefectural Univ. of Med., kyoto, Japan; 2Dept.
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Purpose: Heat shock protein 70 (HSP70) inhibits the apoptosis of
chondrocytes and has the protective effect on the cartilage. Meanwhile,
we reported that mild electrical stimulation (MES) increased HSP70
by attenuating proteasomal degradation and that heat shock (HS)
accelerated the translation of HSP70 in articular chondrocytes. The
purpose of this study is to investigate the effect of MES in combination
with heat shock (HS) on HSP70 in articular cartilage.
Methods: Sprague-Dawley rats (8 weeks of age, 200 g) were divided into
4 groups: Control group, MES group, HS group and HS+MES group. Rats
were anesthetized and electrical stimulation was delivered to their left
knee through a pair of 2.5 cm diameter electro-conductive and thermo-
generative rubber electrodes (45°C) for 30 minutes. The electrodes were
connected to a Biometronome (Tsuchiya Gum Co., Ltd., Kumamoto, Japan)
that delivered 12 V (55 pps) of direct current with individual pulse
duration of 0.1ms. For the control group, rats were sham treated as
above for 30 minutes per session but without conducting HS+MES. Eight
hours after the treatment, protein lysates were obtained from cartilage
fragments and subjected to Western blotting for HSP70 and ubiquitinated
proteins (n = 4 each). Total RNA was isolated from the cartilage 24 hours
after the HS+MES treatment. Relative expressions of mRNA for HSP70
and proteoglycan core protein (PG) were examined by real-time PCR
(n =6 each).
Results: After the treatment, we cannot ﬁnd any adverse effect such as
burn injury or gait disorder. Western blotting showed that HS modestly
augmented HSP70. We found a remarkable increase of HSP70 and
ubiquitinated proteins in HS+MES treated rats compared with the other
groups (Figure 1). Real-time PCR analysis proved that MES did not affect
the HSP70 mRNA. Compared to the control group, the HSP70 mRNA
expression increased in the HS group and HS+MES group, and there
was no signiﬁcant difference between these two groups (Figure 2A). The
expression of PG mRNA was signiﬁcantly enhanced in the HS+MES group
(Figure 2B).
Conclusions: In this study, HSP70 and PG mRNA in articular cartilage
signiﬁcantly increased by MES in combination with HS. HSPs constitute
a family of highly conserved proteins which are synthesized in cells
after stress loading including heat stress. HSP70 not only protect
cells from various forms of stress, but also facilitate the recovery
from stress-induced cell injury as molecular chaperones. We have
reported that adenoviral overexpression of HSP70 resulted in promotion
of PG transcription in chondrocytes, protection of chondrocytes from
heat stress, and inhibition of NO-induced apoptosis of chondrocytes.
Moreover, plasmid delivery of HSP70 in rat patellar cartilage decreased
the severity of osteoarthritis-lesions. In the HS+MES group, PG mRNA
could be induced by the HSP70. From the clinical point of view, effective
and less-invasive method of HSP70 induction in articular chondrocyte
could contribute to the treatment of osteoarthritis. MES and HS have
already used as the safety method of HSP70 induction in vivo and
attenuates hepatic ischemia/reperfusion injury. It is reported that MES
induce HSP70 and ubiquitinated proteins via attenuation of proteasomal
degradation. The elevation of HSP70 and ubiquitinated proteins in
articular cartilage could be also due to the attenuation of proteasomal
